289 related articles for article (PubMed ID: 22349934)
1. Biological influence of Hakai in cancer: a 10-year review.
Aparicio LA; Valladares M; Blanco M; Alonso G; Figueroa A
Cancer Metastasis Rev; 2012 Jun; 31(1-2):375-86. PubMed ID: 22349934
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.
Díaz-Díaz A; Casas-Pais A; Calamia V; Castosa R; Martinez-Iglesias O; Roca-Lema D; Santamarina I; Valladares-Ayerbes M; Calvo L; Chantada V; Figueroa A
J Proteome Res; 2017 Aug; 16(8):2773-2788. PubMed ID: 28675930
[TBL] [Abstract][Full Text] [Related]
3. Hakai reduces cell-substratum adhesion and increases epithelial cell invasion.
Rodríguez-Rigueiro T; Valladares-Ayerbes M; Haz-Conde M; Aparicio LA; Figueroa A
BMC Cancer; 2011 Nov; 11():474. PubMed ID: 22051109
[TBL] [Abstract][Full Text] [Related]
4. miR-203 regulates cell proliferation through its influence on Hakai expression.
Abella V; Valladares M; Rodriguez T; Haz M; Blanco M; Tarrío N; Iglesias P; Aparicio LA; Figueroa A
PLoS One; 2012; 7(12):e52568. PubMed ID: 23285092
[TBL] [Abstract][Full Text] [Related]
5. Hakai overexpression effectively induces tumour progression and metastasis in vivo.
Castosa R; Martinez-Iglesias O; Roca-Lema D; Casas-Pais A; Díaz-Díaz A; Iglesias P; Santamarina I; Graña B; Calvo L; Valladares-Ayerbes M; Concha Á; Figueroa A
Sci Rep; 2018 Feb; 8(1):3466. PubMed ID: 29472634
[TBL] [Abstract][Full Text] [Related]
6. Novel roles of hakai in cell proliferation and oncogenesis.
Figueroa A; Kotani H; Toda Y; Mazan-Mamczarz K; Mueller EC; Otto A; Disch L; Norman M; Ramdasi RM; Keshtgar M; Gorospe M; Fujita Y
Mol Biol Cell; 2009 Aug; 20(15):3533-42. PubMed ID: 19535458
[TBL] [Abstract][Full Text] [Related]
7. Hakai, an E3-ligase for E-cadherin, stabilizes δ-catenin through Src kinase.
Shrestha H; Ryu T; Seo YW; Park SY; He Y; Dai W; Park E; Simkhada S; Kim H; Lee K; Kim K
Cell Signal; 2017 Feb; 31():135-145. PubMed ID: 28069439
[TBL] [Abstract][Full Text] [Related]
8. Hacking RNA: Hakai promotes tumorigenesis by enhancing the RNA-binding function of PSF.
Figueroa A; Fujita Y; Gorospe M
Cell Cycle; 2009 Nov; 8(22):3648-51. PubMed ID: 19855157
[TBL] [Abstract][Full Text] [Related]
9. Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease.
Roca-Lema D; Quiroga M; Khare V; Díaz-Díaz A; Barreiro-Alonso A; Rodríguez-Alonso A; Concha Á; Romay G; Cerdán ME; Gasche C; Figueroa A
Sci Rep; 2022 Oct; 12(1):17571. PubMed ID: 36266428
[TBL] [Abstract][Full Text] [Related]
10. Structure of a novel phosphotyrosine-binding domain in Hakai that targets E-cadherin.
Mukherjee M; Chow SY; Yusoff P; Seetharaman J; Ng C; Sinniah S; Koh XW; Asgar NF; Li D; Yim D; Jackson RA; Yew J; Qian J; Iyu A; Lim YP; Zhou X; Sze SK; Guy GR; Sivaraman J
EMBO J; 2012 Mar; 31(5):1308-19. PubMed ID: 22252131
[TBL] [Abstract][Full Text] [Related]
11. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex.
Fujita Y; Krause G; Scheffner M; Zechner D; Leddy HE; Behrens J; Sommer T; Birchmeier W
Nat Cell Biol; 2002 Mar; 4(3):222-31. PubMed ID: 11836526
[TBL] [Abstract][Full Text] [Related]
12. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
13. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis.
Zhou WJ; Geng ZH; Chi S; Zhang W; Niu XF; Lan SJ; Ma L; Yang X; Wang LJ; Ding YQ; Geng JG
Cell Res; 2011 Apr; 21(4):609-26. PubMed ID: 21283129
[TBL] [Abstract][Full Text] [Related]
14. Essential requirement for RING finger E3 ubiquitin ligase Hakai in early embryonic development of Drosophila.
Kaido M; Wada H; Shindo M; Hayashi S
Genes Cells; 2009 Sep; 14(9):1067-77. PubMed ID: 19682089
[TBL] [Abstract][Full Text] [Related]
15. Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy.
Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):100. PubMed ID: 26791134
[No Abstract] [Full Text] [Related]
16. Targeting neddylation in cancer therapy.
Duncan K; Schäfer G; Vava A; Parker MI; Zerbini LF
Future Oncol; 2012 Nov; 8(11):1461-70. PubMed ID: 23148618
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
18. Role of E3 ubiquitin ligases in gastric cancer.
Hou YC; Deng JY
World J Gastroenterol; 2015 Jan; 21(3):786-93. PubMed ID: 25624711
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in non‑small‑cell lung cancer cells.
Liu Z; Wu Y; Tao Z; Ma L
Int J Mol Med; 2018 Aug; 42(2):1145-1151. PubMed ID: 29786107
[TBL] [Abstract][Full Text] [Related]
20. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
Uchida C; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
